tocilizumab,cevostamab
roche
['mmsm', 'tocilizumab', 'toci', 'cevostamab', 'genentech']
encouraging results of pre-treatment tocilizumab with cevostamab (fcrh5dxcd3 bite ) presented by dr. suzanne trudel decreasing crs rate from 90.9% to 38.7%! rates of neutropenia, infection and g-csf use, but did not affect efficacy #ash22 #mmsm 
Myeloma Clinical Investigator @DanaFarber @harvardmed via @MoffittNews USF Heme/onc, @NorthwesternU BME, Baker, Jersey girl. Views = my own, not employer